Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Muropeptide signature of inhibitors of protein synthesis correlates with β-lactam synergism against methicillin-resistant Staphylococcus aureus.

Guignard B, Majcherczyk PA, Monachon C, Vouillamoz J, Moreillon P.

Int J Antimicrob Agents. 2017 Jan;49(1):53-61. doi: 10.1016/j.ijantimicag.2016.09.028. Epub 2016 Nov 16.

PMID:
27887965
2.

Auto Poisoning of the Respiratory Chain by a Quorum-Sensing-Regulated Molecule Favors Biofilm Formation and Antibiotic Tolerance.

Hazan R, Que YA, Maura D, Strobel B, Majcherczyk PA, Hopper LR, Wilbur DJ, Hreha TN, Barquera B, Rahme LG.

Curr Biol. 2016 Jan 25;26(2):195-206. doi: 10.1016/j.cub.2015.11.056. Epub 2016 Jan 14.

3.

Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response.

Dengler V, Meier PS, Heusser R, Kupferschmied P, Fazekas J, Friebe S, Staufer SB, Majcherczyk PA, Moreillon P, Berger-Bächi B, McCallum N.

FEMS Microbiol Lett. 2012 Aug;333(2):109-20. doi: 10.1111/j.1574-6968.2012.02603.x. Epub 2012 Jun 18.

4.

Prospective monitoring of cefepime in intensive care unit adult patients.

Chapuis TM, Giannoni E, Majcherczyk PA, Chioléro R, Schaller MD, Berger MM, Bolay S, Décosterd LA, Bugnon D, Moreillon P.

Crit Care. 2010;14(2):R51. doi: 10.1186/cc8941. Epub 2010 Apr 1.

5.

MsrR contributes to cell surface characteristics and virulence in Staphylococcus aureus.

Hübscher J, McCallum N, Sifri CD, Majcherczyk PA, Entenza JM, Heusser R, Berger-Bächi B, Stutzmann Meier P.

FEMS Microbiol Lett. 2009 Jun;295(2):251-60. doi: 10.1111/j.1574-6968.2009.01603.x. Epub 2009 May 1.

6.

Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis.

Majcherczyk PA, Barblan JL, Moreillon P, Entenza JM.

Microb Pathog. 2008 Nov-Dec;45(5-6):408-14. doi: 10.1016/j.micpath.2008.09.003. Epub 2008 Sep 27.

PMID:
18930804
7.

Pseudomonas fluorescens CHA0 produces enantio-pyochelin, the optical antipode of the Pseudomonas aeruginosa siderophore pyochelin.

Youard ZA, Mislin GL, Majcherczyk PA, Schalk IJ, Reimmann C.

J Biol Chem. 2007 Dec 7;282(49):35546-53. Epub 2007 Oct 15.

8.

Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus.

Hübscher J, Jansen A, Kotte O, Schäfer J, Majcherczyk PA, Harris LG, Bierbaum G, Heinemann M, Berger-Bächi B.

BMC Genomics. 2007 Sep 4;8:307.

9.

Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.

Pascual A, Nieth V, Calandra T, Bille J, Bolay S, Decosterd LA, Buclin T, Majcherczyk PA, Sanglard D, Marchetti O.

Antimicrob Agents Chemother. 2007 Jan;51(1):137-43. Epub 2006 Nov 6.

10.

Mutational analysis of class A and class B penicillin-binding proteins in Streptococcus gordonii.

Haenni M, Majcherczyk PA, Barblan JL, Moreillon P.

Antimicrob Agents Chemother. 2006 Dec;50(12):4062-9. Epub 2006 Sep 25.

12.

Proinflammatory activity of cell-wall constituents from gram-positive bacteria.

Moreillon P, Majcherczyk PA.

Scand J Infect Dis. 2003;35(9):632-41. Review.

PMID:
14620147
13.

Antibiotic-dependent correlation between drug-induced killing and loss of luminescence in Streptococcus gordonii expressing luciferase.

Loeliger B, Caldelari I, Bizzini A, Stutzmann Meier P, Majcherczyk PA, Moreillon P.

Microb Drug Resist. 2003 Summer;9(2):123-31.

15.

The stereochemistry of the amino acid side chain influences the inflammatory potential of muramyl dipeptide in experimental meningitis.

Cottagnoud P, Gerber CM, Majcherczyk PA, Acosta F, Cottagnoud M, Neftel K, Moreillon P, Täuber MG.

Infect Immun. 2003 Jun;71(6):3663-6.

16.

Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography.

Majcherczyk PA, Moreillon P, Decosterd LA, Sanglard D, Bille J, Glauser MP, Marchetti O.

J Pharm Biomed Anal. 2002 May 15;28(3-4):645-51.

PMID:
12008144
17.

Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles.

Marchetti O, Majcherczyk PA, Glauser MP, Bille J, Moreillon P, Sanglard D.

Antimicrob Agents Chemother. 2001 Mar;45(3):696-700.

18.

The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.

Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J.

Antimicrob Agents Chemother. 1999 Nov;43(11):2753-65.

19.

Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity.

Majcherczyk PA, Langen H, Heumann D, Fountoulakis M, Glauser MP, Moreillon P.

J Biol Chem. 1999 Apr 30;274(18):12537-43.

20.

Serological diagnosis of experimental Enterococcus faecalis endocarditis.

Kjerulf A, Espersen F, Gutschik E, Majcherczyk PA, Hougen HP, Rygaard J, Høiby N.

APMIS. 1998 Oct;106(10):997-1008.

PMID:
9833704
21.

The issue of the true postantibiotic effect.

Majcherczyk PA.

J Antimicrob Chemother. 1996 Jan;37(1):188-90. No abstract available.

PMID:
8647763
22.

Isolation and in-vitro and in-vivo characterisation of a mutant of Pseudomonas aeruginosa PAO1 that exhibited a reduced postantibiotic effect in response to imipenem.

Majcherczyk PA, Kunz S, Hattenberger M, Vaxelaire J, Zak O, O'Reilly T.

J Antimicrob Chemother. 1994 Oct;34(4):485-505. Erratum in: J Antimicrob Chemother 1995 Apr;35(4):561.

PMID:
7646646
23.

Penicillin-binding protein (PBP) 2 and the post-antibiotic effect of carbapenems.

Majcherczyk PA, Livermore DM.

J Antimicrob Chemother. 1990 Oct;26(4):593-4. No abstract available.

PMID:
2254227
24.

Supplemental Content

Loading ...
Support Center